The research focus on pharmacogenomics and individualized medicine at the german BfArM is to investigate the extent to which the genetic predisposition contributes to how a specific patient responds to a drug. There are genetic influences on the breakdown of drugs in the body, metabolism (metabolism).Ultrasound metabolizers are significantly faster in drug use than most people. As a result, this group increases the risk that certain side effects occur or the therapeutic effect does not occur. In the case of poor metabolizers, which degrade the…Continue Reading “Pharmacogenomic diagnostics is part of the German innovation fund 2017”

VIGORIS HEALTHCARE is new consulting and sales partner of Dr. Seibt Genomics . Dr. Seibt Genomics based in the internationally renowned Beta Klinik at Bonner Bogen is a young start UP enterprise which specializes in genetic and pharmacogenomic studies. VIGORIS HEALTHCARE is a specialized consulting and sales company in the German healthcare. Previously, the focus was beside advising healthcare companies (hospitals, medical care centers, doctors’ offices) on the distribution of innovative medical products and services. Now VIGORIS HEALTHCARE can bring his consulting and sales experience…Continue Reading “VIGORIS HEALTHCARE enters genetic terrain”